ITGA7 interacts with FN1 to suppress the PI3K/AKT signaling pathway and inhibit thyroid cancer progression
Hui Yu, Lei Chen, Tao Ma, QiLun Liu, FaXuan Wang · 2026
Read ITGA7 interacts with FN1 to suppress the PI3K/AKT signaling pathway and inhibit thyroid cancer progression by Hui Yu, Lei Chen, Tao Ma, QiLun Liu, FaXuan Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13526741.txt.
Description
Hui Yu and colleagues test, in a 2026 study, whether a cell adhesion protein called ITGA7 restrains thyroid cancer by binding fibronectin and quieting a growth pathway. Thyroid cancer is the commonest endocrine malignancy and usually curable, yet some patients relapse. ITGA7 levels were compared between tumor and neighboring normal tissue.
Expression of ITGA7 was lower in cancers at both message and protein levels, including in cell lines. Removing ITGA7 made cancer cells grow, divide, migrate, and invade more, while resisting cell death. Binding tests confirmed a physical partnership with fibronectin, whose levels rose in tumors and moved opposite to ITGA7. Silencing fibronectin impeded tumor behavior, and pathway blots plus a mouse graft model supported the proposed chain through the PI3K and AKT signaling route.
Catalog record
| CREATOR | Hui Yu, Lei Chen, Tao Ma, QiLun Liu, FaXuan Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46139 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |